{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_12", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "quate and well-controlled studies of [TRADENAME] in \npregnant women.  The limited available information on [TRADENAME] \nuse during pregnancy is not sufficient to inform a drug-associated risk of \nmajor birth defects or miscarriage.  In animal reproduction studies, oral \nadministration of [drugname] to pregnant rats and rabbits during the \nperiod of organogenesis at doses up to 40 and 20 times the maximum \nrecommended human dose (MRHD), respectively, resulted in decreased \nfetal body weight gain"}